Aclaris is currently advancing ATI-2138 in a Phase 2a clinical trial for atopic dermatitis and aims to explore its broader therapeutic potential in multiple inflammatory diseases. Data generated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback